KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Other Non-Current Assets (2020 - 2025)

Recursion Pharmaceuticals' Other Non-Current Assets history spans 6 years, with the latest figure at $12.8 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 44.52% year-over-year to $12.8 million; the TTM value through Dec 2025 reached $12.8 million, up 44.52%, while the annual FY2025 figure was $12.8 million, 44.52% up from the prior year.
  • Other Non-Current Assets reached $12.8 million in Q4 2025 per RXRX's latest filing, down from $14.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $14.7 million in Q3 2025 to a low of $35000.0 in Q3 2021.
  • Average Other Non-Current Assets over 5 years is $5.9 million, with a median of $6.6 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: tumbled 98.85% in 2021, then surged 23197.14% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $35000.0 in 2021, then soared by 23197.14% to $8.2 million in 2022, then dropped by 18.7% to $6.6 million in 2023, then skyrocketed by 33.13% to $8.8 million in 2024, then soared by 44.52% to $12.8 million in 2025.
  • Per Business Quant, the three most recent readings for RXRX's Other Non-Current Assets are $12.8 million (Q4 2025), $14.7 million (Q3 2025), and $5.6 million (Q2 2025).